Company intelligence / Profile preview

Serigen

Pune, Maharashtra, Indiaserigenmed.com ↗

Ownership: Private
Development stage: Commercial

Overview

Serigen is pioneering the use of silk protein-based biomaterials for tissue regeneration. Its lead product "Serioss," an osteoconductive bone void filler, has demonstrated promising results in preclinical studies and initial patient implants. Other products like "Serimat" for soft tissue regeneration and "Seriderm" for advanced wound care have also shown effectiveness, particularly in treating diabetic foot ulcers. The company is the first globally to conduct a clinical trial using silk for bone repair.

Therapeutic areas: OtherEndocrinology
Modalities: Biomaterial-based therapyDevice (wound dressing, bone void filler, tissue matrix)Hydrogel-based drug delivery therapy (inferred from silk scaffold use)
Industry: Therapeutic Medical Devices

Drug pipeline

3 assets

Serioss

Commercial

Indications: Bone defects

2 more assets in the full pipeline.

Request access →

Partnerships

CSIR National Chemical Laboratory

Beyond the preview

Go deeper on Serigen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serigen.

Explore the full profile